NO20090027L - Ny analog av vasoaktivt tarmpeptid - Google Patents

Ny analog av vasoaktivt tarmpeptid

Info

Publication number: NO20090027L
Authority: NO; Norway
Prior art keywords: vasoactive intestinal; intestinal peptide; new analog; analog; new
Prior art date: 2006-07-06

Application number

NO20090027A

Other languages

English (en)

Norwegian (no)

Inventor

David Robert Bolin

Wajiha Khan

Hanspeter Michel

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-07-06

Filing date

2009-01-05

Publication date

2009-01-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38786842&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20090027(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-01-05 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2009-01-15 Publication of NO20090027L publication Critical patent/NO20090027L/no

Links

102000055135 Vasoactive Intestinal Peptide Human genes 0.000 title 1
108010003205 Vasoactive Intestinal Peptide Proteins 0.000 title 1
VBUWHHLIZKOSMS-RIWXPGAOSA-N invicorp Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=C(O)C=C1 VBUWHHLIZKOSMS-RIWXPGAOSA-N 0.000 title 1
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 abstract 1
102100038286 Vasoactive intestinal polypeptide receptor 2 Human genes 0.000 abstract 1
101710137651 Vasoactive intestinal polypeptide receptor 2 Proteins 0.000 abstract 1
230000000414 obstructive effect Effects 0.000 abstract 1
230000002685 pulmonary effect Effects 0.000 abstract 1
239000000018 receptor agonist Substances 0.000 abstract 1
229940044601 receptor agonist Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Endocrinology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Toxicology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Vascular Medicine (AREA)
Rheumatology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

NO20090027A 2006-07-06 2009-01-05 Ny analog av vasoaktivt tarmpeptid NO20090027L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US81880506P	2006-07-06	2006-07-06
PCT/EP2007/056351 WO2008003612A2 (fr)	2006-07-06	2007-06-26	Nouveaux analogues de peptide vasoactif intestinal

Publications (1)

Publication Number	Publication Date
NO20090027L true NO20090027L (no)	2009-01-15

Family

ID=38786842

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20090027A NO20090027L (no)	2006-07-06	2009-01-05	Ny analog av vasoaktivt tarmpeptid

Country Status (20)

Country	Link
US (1)	US20080096807A1 (fr)
EP (1)	EP2041168A2 (fr)
JP (1)	JP2009542593A (fr)
KR (1)	KR20090027239A (fr)
CN (1)	CN101484468A (fr)
AR (1)	AR061825A1 (fr)
AU (1)	AU2007271274A1 (fr)
BR (1)	BRPI0714306A2 (fr)
CA (1)	CA2656757A1 (fr)
CL (1)	CL2007001956A1 (fr)
CR (1)	CR10518A (fr)
EC (1)	ECSP099029A (fr)
IL (1)	IL196122A0 (fr)
MA (1)	MA30590B1 (fr)
MX (1)	MX2009000013A (fr)
NO (1)	NO20090027L (fr)
PE (1)	PE20081000A1 (fr)
RU (1)	RU2009103811A (fr)
TW (1)	TW200819139A (fr)
WO (1)	WO2008003612A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX2012012383A (es)	2010-04-30	2012-11-30	Sanwa Kagaku Kenkyusho Co	Peptido para mejorar la bioestabilidad de una sustancia bioactica y sustancia bioactiva que tiene bioestabilidad mejorada.
CN102827268B (zh) *	2011-06-13	2016-08-24	中肽生化有限公司	新型血管肠肽类似物及其制备方法和用途
US8866872B2 (en)	2011-06-21	2014-10-21	Mitel Networks Corporation	Conferencing and collaboration system and methods thereof
WO2014145718A2 (fr)	2013-03-15	2014-09-18	Longevity Biotech, Inc.	Peptides comprenant des acides aminés non endogènes et procédés de fabrication et d'utilisation associés
US11052132B2 (en) *	2014-05-08	2021-07-06	Phasebio Pharmaceuticals, Inc.	Methods and compositions for treating cystic fibrosis
ITUB20159175A1 (it) *	2015-12-23	2017-06-23	Materie Plastiche Pisane S R L	Composizione polimerica antibatterica

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3879371A (en) *	1971-09-17	1975-04-22	Sami I Said	Isolation of vasoactive intestinal peptide
GB8427651D0 (en) *	1984-11-01	1984-12-05	Beecham Group Plc	Compounds
GB8525852D0 (en) *	1985-10-19	1985-11-20	Beecham Group Plc	Compounds
JPS62246595A (ja) *	1986-04-17	1987-10-27	Eisai Co Ltd	気菅支拡張作用・降圧作用ペプタイド
US4835252A (en) *	1987-02-26	1989-05-30	The Salk Institute Biotechnology/Industrial Associates, Inc.	Vasoactive intestinal peptide analogs
AU656230B2 (en) *	1991-10-11	1995-01-27	F. Hoffmann-La Roche Ag	Cyclic vasoactive peptides
CN1186355C (zh) *	1996-02-09	2005-01-26	霍夫曼-拉罗奇有限公司	血管活性肠肽类似物的合成
US20050203009A1 (en) *	2004-03-12	2005-09-15	Bayer Pharmaceuticals Corporation	VPAC1 selective antagonists and their pharmacological methods of use
EP1781692A2 (fr) *	2004-08-18	2007-05-09	Eli Lilly And Company	Recepteur selectif vpac2 pour agonistes peptidiques
BRPI0516126A (pt) *	2004-10-08	2008-08-26	Forbes Medi Tech Res Inc	produtos farmacêuticos de polipeptìdeos intestinais vasoativos

2007
- 2007-06-26 BR BRPI0714306-0A patent/BRPI0714306A2/pt not_active IP Right Cessation
- 2007-06-26 CN CNA2007800254947A patent/CN101484468A/zh active Pending
- 2007-06-26 RU RU2009103811/10A patent/RU2009103811A/ru unknown
- 2007-06-26 WO PCT/EP2007/056351 patent/WO2008003612A2/fr not_active Ceased
- 2007-06-26 CA CA002656757A patent/CA2656757A1/fr not_active Abandoned
- 2007-06-26 AU AU2007271274A patent/AU2007271274A1/en not_active Abandoned
- 2007-06-26 JP JP2009517165A patent/JP2009542593A/ja active Pending
- 2007-06-26 MX MX2009000013A patent/MX2009000013A/es not_active Application Discontinuation
- 2007-06-26 EP EP07765625A patent/EP2041168A2/fr not_active Withdrawn
- 2007-06-26 KR KR1020097000221A patent/KR20090027239A/ko not_active Ceased
- 2007-07-03 US US11/825,105 patent/US20080096807A1/en not_active Abandoned
- 2007-07-04 TW TW096124342A patent/TW200819139A/zh unknown
- 2007-07-05 AR ARP070102996A patent/AR061825A1/es unknown
- 2007-07-05 PE PE2007000873A patent/PE20081000A1/es not_active Application Discontinuation
- 2007-07-05 CL CL200701956A patent/CL2007001956A1/es unknown
2008
- 2008-12-17 CR CR10518A patent/CR10518A/es not_active Application Discontinuation
- 2008-12-22 IL IL196122A patent/IL196122A0/en unknown
2009
- 2009-01-05 EC EC2009009029A patent/ECSP099029A/es unknown
- 2009-01-05 NO NO20090027A patent/NO20090027L/no not_active Application Discontinuation
- 2009-01-13 MA MA31568A patent/MA30590B1/fr unknown

Also Published As

Publication number	Publication date
BRPI0714306A2 (pt)	2014-05-20
ECSP099029A (es)	2009-02-27
CR10518A (es)	2009-01-27
IL196122A0 (en)	2011-08-01
MX2009000013A (es)	2009-01-23
PE20081000A1 (es)	2008-08-06
MA30590B1 (fr)	2009-07-01
CN101484468A (zh)	2009-07-15
AU2007271274A1 (en)	2008-01-10
KR20090027239A (ko)	2009-03-16
EP2041168A2 (fr)	2009-04-01
JP2009542593A (ja)	2009-12-03
WO2008003612A3 (fr)	2008-02-28
CA2656757A1 (fr)	2008-01-10
AR061825A1 (es)	2008-09-24
TW200819139A (en)	2008-05-01
WO2008003612A2 (fr)	2008-01-10
CL2007001956A1 (es)	2008-04-18
RU2009103811A (ru)	2010-08-20
US20080096807A1 (en)	2008-04-24

Legal Events

Date	Code	Title	Description
2013-02-04	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
MX2009012967A (es)	2010-04-01	Polipeptidos, dominios variables de anticuerpo y antagonistas.
NO20090027L (no)	2009-01-15	Ny analog av vasoaktivt tarmpeptid
WO2008149147A3 (fr)	2009-06-11	Polypeptides, domaines variables d'anticorps et antagonistes
WO2008149144A3 (fr)	2009-04-02	Polypeptides, domaines variables d'anticorps et antagonistes
WO2008051942A3 (fr)	2008-07-03	Agonistes du récepteur farnésoïde x
WO2008082613A3 (fr)	2009-04-09	Conjugués polymère-fraction à activité facteur ix comprenant une liaison dégradable
TW200738632A (en)	2007-10-16	Cannabinoid receptor modulators
WO2010042543A3 (fr)	2011-08-11	Utilisation d'inhibiteurs de récepteurs du type toll dans la prévention et le traitement de l'hypercholestérolémie et de l'hyperlipidémie et de maladies qui y sont associées
WO2006117299A3 (fr)	2007-02-22	Formes cristallines de bromure de tiotropium
WO2007076260A3 (fr)	2007-11-01	Agonistes de recepteur de farnesoide x
MX2011008799A (es)	2011-09-27	Polipeptidos, dominios variables de anticuerpos, y antagonistas anti-tnfr1 mejorados.
WO2012110770A3 (fr)	2012-10-04	Composition pharmaceutique
MY147442A (en)	2012-12-14	Imidazoquinolines as lipid kinase inhibitors
WO2008070111A3 (fr)	2008-08-07	Procédés de préparation de (r)-8-chloro-1-méthyl-2,3,4,5-tétrahydro-1h-3-benzazépine et intermédiaires de celle-ci
WO2004050610A3 (fr)	2004-08-26	Modulateurs du recepteur de la melanocortine
WO2010149578A3 (fr)	2011-07-14	Nouveaux amides de biphényl- et phényl-pyridine
WO2009053339A3 (fr)	2010-06-17	Dérivés de cholestérol d'inhibiteurs de la fusion virale
WO2010048477A3 (fr)	2011-02-24	Procede ameliore de preparation de produits couples a partir de 4-amino-3-cyanoquinoleines utilisant des intermediaires stabilises
WO2006117300A3 (fr)	2007-04-26	Formes cristallines de bromure de tiotropium
MXPA04010625A (es)	2004-12-13	Antagonista de receptor de taquicinina.
MY162095A (en)	2017-05-31	Method of treating symptoms of hormonal variations
MX2009008527A (es)	2009-08-27	Compuestos de amonio cuaternario y difenilmetilo utiles como antagonistas del receptor muscarinico.
WO2007079163A3 (fr)	2007-08-30	Antagonistes du recepteur de la prokineticine 1
SE0800742L (sv)	2009-10-03	Vikttäcke
TW200720236A (en)	2007-06-01	Organic compounds